Literature DB >> 1331453

Effects of alkyl substitutions of xanthine skeleton on bronchodilation.

R Sakai1, K Konno, Y Yamamoto, F Sanae, K Takagi, T Hasegawa, N Iwasaki, M Kakiuchi, H Kato, K Miyamoto.   

Abstract

Structure-activity relationships in a series of 1,3,7-trialkyl-xanthine were studied with guinea pigs. Relaxant actions in the tracheal muscle were increased with alkyl chain length at the 1- and 3-positions of the xanthine skeleton, but decreased by alkylation at the 7-position. Positive chronotropic actions in the right atrium were potentiated with 3-alkyl chain length but tended to decrease with 1-alkylation and diminish by 7-substitution. Consequently, while the 1- and 3-substitutions were equally important for the tracheal smooth muscle relaxation, the substitution at the 1-position was more important than the 3-substitution for bronchoselectivity. The 7-alkylation may be significant to cancel heart stimulation. There were good correlations between the smooth muscle relaxant action and the cyclic AMP-PDE inhibitory activity in 3-substituents and the affinity for adenosine (A1) receptors in 1-, 3-, and 7-substituents. This suggests that not only the cyclic AMP-PDE inhibitory activity but also the adenosine antagonistic activity is important in the bronchodilatory effects of alkylxanthines. Among these xanthine derivatives, 1-butyl-3-propylxanthine and its 7-methylated derivative showed high bronchoselectivity in the in vitro and in vivo experiments compared to theophylline and enprofylline and may be new candidates for bronchodilator.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1331453     DOI: 10.1021/jm00100a008

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  5 in total

1.  Analyzing airway inflammation with chemical biology: dissection of acidic mammalian chitinase function with a selective drug-like inhibitor.

Authors:  Tara E Sutherland; Ole A Andersen; Marie Betou; Ian M Eggleston; Rick M Maizels; Daan van Aalten; Judith E Allen
Journal:  Chem Biol       Date:  2011-05-27

2.  Inhibitory effects of caffeine analogues on neoplastic transformation: structure-activity relationship.

Authors:  Evgeny A Rogozin; Ki Won Lee; Nam Joo Kang; Haoyu Yu; Masaaki Nomura; Ken-Ichi Miyamoto; Allan H Conney; Ann M Bode; Zigang Dong
Journal:  Carcinogenesis       Date:  2008-01-14       Impact factor: 4.944

3.  Effects of 1-methyl-3-propyl-7-butylxanthine (MPBX) on idarubicin-induced antitumor activity and bone marrow suppression.

Authors:  Y Sadzuka; Y Egawa; T Sugiyama; H Sawanishi; K Miyamoto; T Sonobe
Journal:  Jpn J Cancer Res       Date:  2000-06

4.  1-Methyl-3-propyl-7-butylxanthine, a novel biochemical modulator, enhances therapeutic efficacy of adriamycin.

Authors:  Y Sadzuka; A Iwazaki; T Sugiyama; T Sawanishi; K Miyamoto
Journal:  Jpn J Cancer Res       Date:  1998-02

Review 5.  Xanthine scaffold: scope and potential in drug development.

Authors:  Nivedita Singh; Ashwinee Kumar Shreshtha; M S Thakur; Sanjukta Patra
Journal:  Heliyon       Date:  2018-10-03
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.